Xpreza Injection (Azacitidine): Chemotherapy Injection | For Myelodysplastic Syndromes (MDS), Acute Myeloid Leukemia (AML) Management

Precautions

Xpreza Injection (Azacitidine) requires careful medical supervision because it can lower blood cell counts, increasing the risk of infections, bleeding, and anaemia. It may also affect liver and kidney function. Certain existing health conditions and medicines can increase these risks, so proper monitoring is important throughout treatment.

Before You Start

• Check for allergies: Inform your doctor if you have previously experienced an allergic reaction to azacitidine or any of the injection's ingredients.

• Discuss kidney problems: Tell your doctor if you have kidney disease or a history of kidney-related complications, as treatment may affect kidney function.

• Mention liver conditions: Inform your doctor if you have liver disease or abnormal liver test results.

• Share your blood count history: Tell your doctor if you have low blood cell counts, frequent infections, anaemia, or a history of unusual bleeding.

• Inform about other medicines: Share details of all prescription medicines, supplements, and herbal products you take, especially those that may affect blood counts or increase bleeding risk.

• Pregnancy and breastfeeding: Inform your doctor if you are pregnant, planning a pregnancy, or breastfeeding. Azacitidine may harm an unborn baby, and breastfeeding is not recommended during treatment.

While Using It

• Follow the treatment schedule: Receive Xpreza Injection exactly as prescribed. Do not miss appointments or change the treatment schedule without medical advice.

• Monitor blood counts: Attend regular blood tests to check red blood cells, white blood cells, and platelets, as azacitidine can lower their levels.

• Take infection precautions: Maintain good hygiene and avoid close contact with people who have contagious infections. Report fever, chills, or a persistent sore throat promptly.

• Watch for bleeding: Be alert for unusual bruising, nosebleeds, bleeding gums, or blood in your urine or stools.

• Maintain adequate hydration: Drink sufficient fluids as advised by your doctor, particularly during treatment, to support kidney function.

• Attend regular checkups: Your doctor may monitor liver function, kidney health, blood counts, and treatment response throughout therapy.

When to Seek Medical Help

• Signs of infection: Seek immediate medical advice if you develop a fever, chills, persistent cough, or other signs of infection.

• Unusual bleeding: Report blood in your stools or urine, prolonged bleeding, or unexplained bruising without delay.

• Severe weakness or breathlessness: Inform your doctor if you experience unusual tiredness, dizziness, or difficulty breathing, as these may indicate low blood cell counts.

• Kidney-related symptoms: Report reduced urination, swelling, or sudden changes in your urine output.

• Severe allergic reactions: Seek emergency care if you experience facial swelling, breathing difficulties, or a severe skin reaction.

Note:

Xpreza Injection should be administered under the supervision of a qualified healthcare professional. Regular blood count monitoring is especially important because azacitidine can significantly reduce blood cell levels. Do not ignore signs of infection or unusual bleeding, and inform your doctor about any new or worsening symptoms during treatment.

Usage

• Follow the prescribed treatment schedule: Xpreza Injection (Azacitidine) is administered by a qualified healthcare professional. The dose and treatment schedule depend on your condition, blood test results, and response to treatment.

• Complete the planned treatment cycles: Azacitidine is generally given in repeated treatment cycles. Attend all scheduled appointments, as several cycles may be needed to assess how well the treatment is working.

• Do not miss appointments: If you cannot attend a scheduled injection, contact your healthcare team to arrange another appointment. Do not try to adjust the treatment schedule yourself.

• Share your medical history: Inform your doctor about existing kidney or liver problems, previous treatments, allergies, and all medicines or supplements you take.

• Monitor blood counts: Regular blood tests are important because azacitidine can affect blood cell levels, including red blood cells, white blood cells, and platelets.

• Watch for unexpected changes: Report fever, unusual bruising, bleeding, severe tiredness, or signs of infection to your healthcare team promptly.

• Follow injection-site care: If the injection is given under the skin, follow your healthcare professional's advice regarding the injection area and any redness, swelling, or discomfort.

Uses

Xpreza Injection contains Azacitidine, an anticancer medicine belonging to a group called hypomethylating agents. It is used to treat certain blood and bone marrow disorders by affecting the growth and development of abnormal blood cells.

• Myelodysplastic Syndromes (MDS): Used to treat certain types of MDS, where the bone marrow does not produce healthy blood cells properly.

• Acute Myeloid Leukaemia (AML): May be used in specific treatment settings for AML, depending on the patient's condition and treatment plan.

• Chronic Myelomonocytic Leukaemia (CMML): May be prescribed for certain cases of CMML, depending on the approved indication and clinical assessment.

• Affects abnormal cell growth: Azacitidine interferes with abnormal DNA-related processes in cells, helping regulate the growth and development of abnormal blood cells.

• Supports bone marrow function: Treatment may help improve blood cell production in some patients, depending on their response.

Summary

Xpreza Injection is used to manage certain blood and bone marrow disorders by targeting abnormal cell growth. Treatment requires regular injections, blood tests, and medical monitoring. Follow your oncologist's instructions carefully and report any unusual symptoms during treatment.

Side Effects

Xpreza Injection contains azacitidine, a medicine used to treat certain blood and bone marrow disorders, including myelodysplastic syndromes (MDS). It works by affecting abnormal cell growth and can also influence the production of healthy blood cells. As a result, some patients may experience side effects during treatment. These can vary depending on the treatment cycle and individual response.

Common Side Effects

• Nausea and vomiting: You may feel sick or experience vomiting after treatment.

• Anaemia: Reduced red blood cells may cause tiredness, weakness, or breathlessness.

• Low blood cell counts: Reduced white blood cells or platelets may increase the risk of infections and bleeding.

• Diarrhoea or constipation: You may experience changes in bowel movements.

• Fever: A rise in body temperature may occur during treatment.

• Injection site reactions: Redness, pain, swelling, or bruising may develop where the injection is given.

• Weakness and fatigue: You may feel unusually tired or have less energy.

• Loss of appetite: You may notice reduced interest in food.

Serious Side Effects

• Severe infections: A significant drop in white blood cells may make it harder for your body to fight infections. Fever, chills, or persistent cough need prompt medical attention.

• Unusual bleeding or bruising: Low platelet counts may cause nosebleeds, bleeding gums, or unexplained bruises.

• Severe anaemia: Very low red blood cell counts may cause breathlessness, dizziness, or extreme weakness.

• Kidney problems: Changes in kidney function may occur and require medical monitoring.

• Liver problems: Yellowing of the skin or eyes, dark urine, or unusual abdominal discomfort should be reported.

• Tumour lysis syndrome: Rapid breakdown of abnormal cells can cause dangerous changes in blood chemicals and may affect kidney function.

• Severe allergic reactions: Swelling of the face or throat, rash, or difficulty breathing requires emergency medical attention.

Note: Xpreza Injection should only be administered under the supervision of an experienced healthcare professional. Regular blood tests and kidney and liver function monitoring are important during treatment. Report fever, unusual bleeding, severe weakness, or signs of infection promptly. Do not skip scheduled monitoring or change your treatment without consulting your doctor.

FAQs

1. What is Xpreza Injection used for?

Xpreza Injection contains azacitidine and is used to treat certain blood and bone marrow disorders, including myelodysplastic syndromes (MDS), acute myeloid leukaemia (AML) in eligible patients, and chronic myelomonocytic leukaemia (CMML).

2. How does Xpreza Injection work?

Azacitidine works by affecting DNA-related processes in abnormal bone marrow cells. It helps regulate abnormal cell growth and allows healthier blood cell development in some patients.

3. How is Xpreza Injection administered?

Xpreza Injection is usually given under the skin or directly into a vein by a trained healthcare professional. The route and dose depend on your condition and treatment plan.

4. How often is Xpreza Injection given?

It is commonly administered in treatment cycles, often once daily for seven consecutive days in a 28-day cycle. Your doctor may adjust the schedule depending on your response and blood test results.

5. What are the common side effects of Xpreza Injection?

Common side effects may include nausea, vomiting, diarrhoea, constipation, tiredness, fever, reduced appetite, and redness or pain at the injection site.

6. Can Xpreza Injection affect blood cell counts?

Yes. It can lower red blood cells, white blood cells, and platelets. This may increase the risk of anaemia, infections, and bleeding, so regular blood tests are important during treatment.

7. What precautions should I take during treatment with Xpreza Injection?

Attend scheduled blood tests, maintain good hygiene, and report fever, unusual bruising, bleeding, or signs of infection promptly. Follow your doctor's advice throughout treatment.

8. Can Xpreza Injection be used during pregnancy?

Azacitidine may harm an unborn baby. Women who can become pregnant should use effective contraception during treatment and for six months after the last dose. Men with partners who can become pregnant should use contraception during treatment and for three months afterwards.

9. What should I do if I miss a scheduled dose of Xpreza Injection?

Contact your doctor or treatment centre if you miss an appointment. Your healthcare team will advise when to receive the next dose. Do not try to adjust the treatment schedule yourself.

10. How long does Xpreza Injection treatment continue?

Treatment is generally given in repeated cycles. The duration depends on how well you respond, your blood test results, and how you tolerate the medicine. Your doctor will decide whether to continue treatment.